Home > Encyclopedia of Food & Culture > Folic Acid

FOLIC ACID. Folic acid is a water-soluble B-vitamin first identified in 1930 by Wills and Mehta as "Wills factor." Wills factor cured the anemias of pregnant women in India, a clinical condition that commonly results from undernutrition. This vitamin was later isolated from spinach leaves and named folic acid (Latin folium, leaf). Unlike most bacteria and yeast, mammals cannot synthesize folate and, therefore, require folate in the diet. This vitamin is present in the body as a family of at least nine structurally related chemical compounds that are collectively referred to as folate. The term folic acid refers to a synthetic form of the vitamin. Folic acid, which is biologically inactive, is found in foods that have been fortified with it. Folic acid is also the form that is present in nutritional supplements. Folic acid can be converted by living cells to a biologically active form called tetrahydrofolate. This active form serves the same biological function as natural folates. The terms "folic acid" and "folate" are therefore often used interchangeably.

Chemical Forms of Folate

The different forms of folate found in the body exist primarily as modified forms of tetrahydrofolate. Each tetrahydrofolate form differs by modification of the selected positions in the molecule that involve the placement of a single carbon unit. Additionally, folate derivatives found in cells contain a glutamate polypeptide tail that consists of two to eight glutamate residues in length. This polyglutamate chain is required for folates to perform their biochemical functions and also to retain folate in the cell. The glutamate chain prevents the molecule from crossing cell membranes.

Dietary Folate

Vegetables are good dietary sources of naturally occurring folate, especially dark green leafy vegetables. Citrus fruits and fresh juices, berries, legumes, liver, and whole grains are other good sources. Most naturally occurring folates are sensitive to degradation by air and heat but are stabilized when bound to proteins present in foods. For this reason, fresh fruits and vegetables are the best sources of dietary folates since many food folates are destroyed during food preparation. Dietary folates contain a polyglutamate chain that must be removed by digestive enzymes in the intestine. These enzymes leave a single glutamate residue on the folate, and the folate is then absorbed by the intestinal cell. Most folates are taken up by the liver, which is the primary storage site for folate. Folates can then be redistributed to other tissues from the liver. Glutamate chains are re-elongated by the body after the absorption of folates with single glutamates.

Overview of Folate Metabolism

Folate serves as a cofactor that delivers single carbon units to particular enzymes that catalyze biochemical reactions. These folate-dependent biochemical reactions are referred to collectively as one-carbon metabolism. Folate functions in both the cytoplasm and mitochondria, the energy-producing units, of mammalian cells. Folate metabolism in mitochondria is responsible for the generation of formate, a source of one-carbon unit. Formate escapes the mitochondria and is a primary source of the single carbon units for one-carbon metabolism in the cytoplasm. One-carbon metabolism in the cytoplasm is required for the synthesis of DNA precursors, and the amino acid methionine from its precursor, homocysteine. Methionine, in turn, is converted to the cofactor S-adenosylmethionine or SAM. SAM serves as an additional source of single carbon units in the form of methyl groups that are required for other metabolic reactions including the methylation of DNA, RNA, and proteins. SAM also is required for the synthesis of phospholipids, neurotransmitters, and many small metabolites.

Folate as a Therapeutic Target

Folate-dependent reactions are fundamental for DNA synthesis and maintenance of DNA integrity. Therefore, folate is required for cell growth and replication. It is not surprising that folate-dependent enzymes have proven to be effective targets for antitumor and antimicrobial drug therapies. These pharmaceutical agents are structurally similar to folate and are referred to as antifolates. Agents including 5-fluorouracil and methotrexate (and related antifolates) bind to folate-dependent enzymes by mimicking the structure of folate but do not serve the same biological function. These agents enter the cell and inhibit folate-dependent reactions associated with DNA synthesis and result in cell death. Antifolates are used in the treatment of many cancers, Crohn's disease, rheumatoid arthritis, lupus, and other autoimmune disorders.

Folate Deficiency and Disease

The most common impairments of folate metabolism result from inadequate folate intake, certain drug therapies, smoking, malabsorption disorders, alcoholism, genetic mutations, and subtle individual genetic variations that occur normally in populations. Additionally, certain dietary factors can interfere with folate absorption in the gut and result in malabsorption of the vitamin. Inadequate folate status has been reported in many population groups including pregnant and lactating women, women twenty to forty-four years of age, adolescents, and the elderly. Folate requirements are greatly increased during pregnancy due to the high demand for folate by the growing fetus and placenta. Folate deficiency can present itself clinically as megaloblastic anemia, a clinical condition associated with enlarged red blood cells due to decreased DNA synthesis. Other clinical symptoms include an inflamed, redlooking tongue, nausea, vomiting, diarrhea, anorexia, hyperpigmentation, and fever. Folate deficiency during pregnancy is highly associated with several congenital defects including spina bifida. Population studies implicate impaired folate metabolism in other pathologies including cardiovascular disease, colon cancer, cervical dysplasia, and pre-eclampsia.

Folate and Homocysteine

One of the first biochemical indicators associated with impaired folate metabolism is increased serum homocysteine (resulting from decreased methionine synthesis). Both folate and vitamin B₁₂ are required for converting homocysteine to methionine. Plasma homocysteine level is a sensitive marker of folate status, but homocysteine can be influenced by other vitamins, including vitamin B₆ and B₁₂ status, as well as age. The relationship between folic acid and homocysteine levels in the body is important because of the association between homocysteine and vascular disease. Elevated plasma homocysteine is now considered an independent risk factor for atherosclerotic vascular disease. The risk of cardiovascular disease rises in proportion to an individual's serum homocysteine concentrations. Some studies also suggest an independent role of folate deficiency in cardiovascular disease. The relationship between homocysteine and disease is not understood, but two mechanisms are the focus of current research. Homocysteine contains a reactive thiol group that can modify proteins and affect their function. Alternatively, homocysteine can also be converted to S-adenosylhomocysteine, which is a potent inhibitor of many methylation reactions that modify DNA proteins and influences gene expression. Either or both of these mechanisms may account for pathologies that are associated with elevated homocysteine in humans.

Dietary Recommendations

In 1998, the National Academy of Sciences released the Dietary Reference Intake (DRI) values for folate that include a recommended dietary allowance (RDA) of 400 micrograms for males and females aged fourteen years and younger. For these individuals, the source of folate is not important. However, it is recommended that women of childbearing age consume an additional 400 micrograms of folic acid per day from fortified foods and/or supplements in addition to the intake of food folate from a varied diet. It is critical that women be folate-sufficient prior to pregnancy, since most birth defects that result from folate deficiency occur before the twenty-ninth day of pregnancy, often before the woman realizes she is pregnant. Maintaining adequate folate status is especially critical for women with a history of bearing children with neural tube defects, to prevent future incidence of birth defects. Pregnant women should consume an additional 600 micrograms of synthetic folate per day in addition to a naturally folate-rich diet. It is not normally recommended that anyone consume more than 1 milligram of folate per day.

The RDA is expressed as dietary folate equivalents (DFEs) because synthetic folic acid is more easily absorbed in the intestine than naturally occurring folate. One microgram of naturally occurring food folate is equivalent to 0.6 microgram of folic acid from fortified foods or supplements consumed with meals and to 0.5 microgram of supplements not consumed with meals. Because of recent federal regulations for food fortification, synthetic folic acid can now be found not only in dietary supplements, but also in enriched grain products (0.43 to 1.4 micrograms of folic acid per pound grain product) such as flour and pasta. Initial results from the fortification program indicate that plasma folate levels have more than doubled among adults who do not use folic acid supplements. The effect of this program on reducing spina bifida and other folate-associated birth defects and pathologies is yet to be determined.

See also Fiber, Dietary; Vegetables.

Patrick J. Stover